We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
Human iPSC- and Primary-Retinal Pigment Epithelial Cells for Modeling Age-Related Macular Degeneration.
- Authors
Fisher, Cody R.; Ebeling, Mara C.; Geng, Zhaohui; Kapphahn, Rebecca J.; Roehrich, Heidi; Montezuma, Sandra R.; Dutton, James R.; Ferrington, Deborah A.
- Abstract
Primary cultures of retinal pigment epithelium (RPE) from human adult donors (haRPE) and induced pluripotent stem cell derived-RPE (iPSC-RPE) are valuable model systems for gaining mechanistic insight and for testing potential therapies for age-related macular degeneration (AMD). This study evaluated the treatment response of haRPE and iPSC-RPE to oxidative stress and potential therapeutics addressing mitochondrial defects. haRPE and iSPC-RPE were derived from donors with or without AMD. Mitochondrial function was measured after treatment with menadione, AICAR, or trehalose and the response to treatment was compared between cell models and by disease status. In a subset of samples, haRPE and iPSC-RPE were generated from the same human donor to make a side-by-side comparison of the two cell models' response to treatment. Disease-specific responses to all three treatments was observed in the haRPE. In contrast, iPSC-RPE had a similar response to all treatments irrespective of disease status. Analysis of haRPE and iPSC-RPE generated from the same human donor showed a similar response for donors without AMD, but there were significant differences in treatment response between cell models generated from AMD donors. These results support the use of iPSC-RPE and haRPE when investigating AMD mechanisms and new therapeutics but indicates that attention to experimental conditions is required.
- Subjects
TREHALOSE; PLURIPOTENT stem cells; RHODOPSIN; RETINAL degeneration; CHROMATOPHORES; EPITHELIAL cells
- Publication
Antioxidants, 2022, Vol 11, Issue 4, pN.PAG
- ISSN
2076-3921
- Publication type
Article
- DOI
10.3390/antiox11040605